Showing results (261-270 of 457) with videos related to

Sort By:
Pageof 46
Clinical Chemistry|April 2, 1999
Multicenter trial of the quantitative BTA TRAK assay in the detection of bladder cancerL Thomas, H Leyh, M Marberger, et al.
European Urology|June 9, 2012
A systematic review of neoadjuvant and adjuvant chemotherapy for muscle-invasive bladder cancerJoshua J Meeks, Joaquim Bellmunt, Bernard H Bochner, et al.
European Urology|January 26, 2021
Genomic Testing in Patients with Metastatic Castration-resistant Prostate Cancer: A Pragmatic Guide for CliniciansAxel S Merseburger, Nick Waldron, Maria J Ribal, et al.
JAMIA Open|June 19, 2026
Enhancing the quality and trustworthiness of large language model-generated summaries of clinical oncology literatureArnulf Stenzl, Eamonn Rogers, Sophia Ananiadou, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 16, 2012
Effect of abiraterone acetate on fatigue in patients with metastatic castration-resistant prostate cancer after docetaxel chemotherapyC N Sternberg, A Molina, S North, et al.
BJU International|March 30, 2010
Management of prostate cancer in older men: recommendations of a working group of the International Society of Geriatric OncologyJean-Pierre Droz, Lodovico Balducci, Michel Bolla, et al.
Critical Reviews in Oncology/Hematology|October 20, 2009
Background for the proposal of SIOG guidelines for the management of prostate cancer in senior adultsJean-Pierre Droz, Lodovico Balducci, Michel Bolla, et al.
Anticancer Research|November 2, 2010
Clinical and molecular determinants of survival in pancreatic cancer patients treated with second-line chemotherapy: results of an Italian/Swiss multicenter surveyA Mancuso, S Sacchetta, P C Saletti, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 16, 2001
Randomized phase III trial of high-dose-intensity methotrexate, vinblastine, doxorubicin, and cisplatin (MVAC) chemotherapy and recombinant human granulocyte colony-stimulating factor versus classic MVAC in advanced urothelial tract tumors: European Organization for Research and Treatment of Cancer Protocol no. 30924C N Sternberg, P H de Mulder, J H Schornagel, et al.
Prostate Cancer and Prostatic Diseases|February 22, 2022
Real-world patient characteristics associated with survival of 2 years or more after radium-223 treatment for metastatic castration-resistant prostate cancer (EPIX study)Daniel J George, Neeraj Agarwal, Oliver Sartor, et al.
Pageof 46